| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9439f91aba2706da33e767897be17a6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2015-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf96b8af0385710466bd61c92a11fc1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d67d2b2e7d39e2b735ac4e56c2d7bb5c |
| publicationDate |
2015-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015197579-A1 |
| titleOfInvention |
Method for diagnosing the risk of preneoplastic and neoplastic liver disease in subjects affected by hepatitis |
| abstract |
The invention herein described relates to an early and specific diagnosis method based on the use of the peptide fragment 75-99 of the URG7 protein. This peptide is used as an antigen to determine the presence of anti-URG7 antibodies in the sera of carrier subjects of the hepatitis virus, of hepatitis B in particular. |
| priorityDate |
2014-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |